Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 8802644
Lipid formulation
granted -
US 8802844
Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis
granted -
US 8802836
Cloning and recombinant productions of Vespula venom protease and methods of use thereof
granted -
US 8802698
8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
granted -
US 8802699
Quinuclidine derivatives and medicinal compositions containing the same
granted -
US 8802733
Aldehyde dehydrogenase inhibitors as novel depigmenting agents
granted -
US 8802773
In vivo polynucleotide delivery conjugates having enzyme sensitive linkages
granted -
WO 2014117863
FORMES POLYMORPHES DE SELS D'ADDITION D'ACIDE DE THIOXANTHÈNE-9-YLIDÈNE-1-MÉTHYLPIPÉRIDINES UTILISÉS COMME COMPOSÉS ANTIMIGRAINEUX
granted -
US 8796438
Nucleic acids encoding inactive variants of human telomerase
granted -
US 8796308
Modulators of cystic fibrosis transmembrane conductance regulator
granted -
US 8796332
Compositions and methods for controlling infections
granted -
US 8796428
Erk1/2 posphorylation site specific antibody
granted -
US 8795738
Use of arsenic for cancer therapy protection
granted -
US 8796259
N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as axl inhibitors
granted -
US 8796312
Heteroaryl derivatives as CFTR modulators
granted -
US 8796248
Oligomer-corticosteroid conjugates
granted -
US 8796327
Method for inhibiting production of cytokines of T helper cell type II and/or inhibiting production of chemokines using brazilin
granted -
US 8796436
Modified iRNA agents
granted -
US 8796320
1,3,4-Oxadiazole-2-carboxamide compound
granted -
US 8796302
Methods related to the treatment of neurodegenerative and inflammatory conditions
granted -
US 8796270
N-[6-(1H-indazol-6-yl)imidazo[1,2-A]pyridin-8-yl]-6-(morpholin-4-yl)pyridazin-3-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
granted -
US 8796291
A3 adenosine receptor antagonists and partial agonists
granted -
US 8796254
Methods for using carboxamide, sulfonamide and amine compounds
granted -
US 8796233
Methods and systems for modulating hormones and related methods, agents and compositions
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.